However, with respect to other markers of liver dysfunction MARS was superior over SPAD in removing bile acids and improving albumin binding capacity (ABiC)10 and OPAL superior over MARS for both markers (OPALESCE trial). This evidence concerns the gene ALB and Decreased liver function.